Lacoset (Vimpat)50 Mg – 50 tablet

USD $17.07

Each Lacoset contains 50 mg Lacosamide 50 tablets per box. It an anticonvulsant used for the treatment of seizures in adults.

ATC Classification: N03AX18
Active Ingrediant: Lacosamide
Generic Name: Lacoset
Manufacturer: Sun Pharma
Strength: 50 Mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 50 Tab

Examples of Packages sent

What is this drug used for?

– It is used to treat seizures.

Frequently reported side effects of this drug

– Fatigue

– Loss of strength and energy

– Headache

– Blurred vision

– Nausea

– Vomiting

– Diarrhea

– Dry mouth

– Sweating a lot.

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

– Depression like thoughts of suicide, anxiety, emotional instability, agitation, irritability, panic attacks, mood changes, behavioral changes, or confusion

– Liver problems like dark urine, fatigue, lack of appetite, nausea, abdominal pain, light-colored stools, vomiting, or yellow skin.

– Change in balance

– Trouble with memory

– Severe dizziness

– Passing out

– Slow heartbeat

– Fast heartbeat

– Abnormal heartbeat

– Tremors

– Double vision

– Shortness of breath

– Swollen glands

– Chest pain

– Burning or numbness feeling

– Involuntary eye movements

– Unable to pass urine

– Change in amount of urine passed

– Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

Note:?This is not a comprehensive list of all side effects. Talk to your doctor if you have questions.



(la KOE sa mide)


Medication Safety Issues

Sound-alike/look-alike issues:

Lacosamide may be confused with zonisamide

Vimpat may be confused with Venofer, Vfend, Vimovo


Storage and Stability

Injection: Store at 20?C to 25?C (68?F to 77?F); excursions are permitted between 15?C and 30?C (59?F and 86?F). Do not freeze. Stable when mixed with compatible diluents (NS, LR, D5W) for up to 4 hours at room temperature; extended storage information for prepared solution at room temperature may be available; contact product manufacturer to obtain current recommendations. Discard any unused portion.

Oral solution, tablets: Store at 20?C to 25?C (68?F to 77?F); excursions are permitted between 15?C and 30?C (59?F and 86?F). Do not freeze oral solution. Discard any unused portion of oral solution after 7 weeks.


Adverse Reactions

Cardiovascular: Palpitations, syncope

Central nervous system: Abnormal gait, ataxia, cerebellar syndrome, cognitive dysfunction, confusion, depression, disturbance in attention, dizziness, drowsiness, dysarthria, equilibrium disturbance, falling, fatigue, headache, hypoesthesia, intoxicated feeling, irritability, mood changes, paresthesia, suicidal ideation, suicidal tendencies, vertigo

Dermatologic: Pruritus

Gastrointestinal: Constipation, diarrhea, dyspepsia, nausea, oral hypoesthesia, vomiting, xerostomia

Hematologic & oncologic: Anemia, bruise, neutropenia

Local: Local irritation (IV), pain at injection site (IV)

Neuromuscular & skeletal: Asthenia, muscle spasm, tremor

Ophthalmic: Blurred vision, diplopia, nystagmus

Otic: Tinnitus

Miscellaneous: Fever, laceration

Rare but important or life-threatening: Abnormal hepatic function tests, acute psychosis, aggressive behavior, agitation, agranulocytosis, angioedema, atrial fibrillation, atrial flutter, atrioventricular block, bradycardia, cardiac arrhythmia, DRESS syndrome, erythema at injection site, euphoria, first degree atrioventricular block, hallucination, hepatitis, increased serum alanine aminotransferase, insomnia, nephritis, prolongation P-R interval on ECG, seizure, skin rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, urticaria, ventricular tachyarrhythmia

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , ,


Dosage Type

Packaging Type


Sun Pharma


There are no reviews yet.

Be the first to review “Lacoset (Vimpat)50 Mg – 50 tablet”

Your email address will not be published. Required fields are marked *